Lung cancer - Time to move on from chemotherapy

[1] Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501

[2] REDUCING TOBACCO CONSUMPTION IN CALIFORNIA - DEVELOPMENT OF A STATEWIDE ANTITOBACCO USE CAMPAIGN [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (12): : 1570 - 1574

[3] Baselga J, 2001, J CLIN ONCOL, V19, p41S

[4] Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: Perceptible progress [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1794 - 1801

[5] Cancer statistics, 2001 [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) : 15 - 36

[6] Greenlee RT, 2001, CA-CANCER J CLIN, V51, P144

[7] Early Lung Cancer Action Project: overall design and findings from baseline screening [J]. LANCET, 1999, 354 (9173) : 99 - 105

[8] Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (18): : 1385 - 1391

[9] Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group trial [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) : 3210 - 3218

[10] Differential frequencies of p16INK4a promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) : 3221 - 3229

[1] Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501

[2] REDUCING TOBACCO CONSUMPTION IN CALIFORNIA - DEVELOPMENT OF A STATEWIDE ANTITOBACCO USE CAMPAIGN [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (12): : 1570 - 1574

[3] Baselga J, 2001, J CLIN ONCOL, V19, p41S

[4] Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: Perceptible progress [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1794 - 1801

[5] Cancer statistics, 2001 [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) : 15 - 36

[6] Greenlee RT, 2001, CA-CANCER J CLIN, V51, P144

[7] Early Lung Cancer Action Project: overall design and findings from baseline screening [J]. LANCET, 1999, 354 (9173) : 99 - 105

[8] Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (18): : 1385 - 1391

[9] Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group trial [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) : 3210 - 3218

[10] Differential frequencies of p16INK4a promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) : 3221 - 3229